Sales

COVID-19 alters GP and pharmaceutical field staff engagement – according to survey

Health Industry Hub | June 17, 2020 |
[Total: 1    Average: 4/5]

With the sudden and dramatic impact of COVID-19, a survey of GPs and their contact with pharmaceutical field staff during the pandemic reveals a massive drop in face-to-face engagement.

The joint Australian Doctor Group and Medicines Australia poll was sent out in mid-May and attracted almost 400 responders.

It shows prior to the pandemic half of GPs would see a rep at least once a month or more, however, in the wake of social distancing measures, 79% of GPs have not been contacted and only 5% have reported a visit in person.

Instead, GPs have seen increases in field staff attempting to contact them by phone (22% compared with 16% last year) along with email which has also risen to 37% (up from 30% last year).

While these changes may be expected, a more surprising results was the uplift in video conferencing, that moved from only 1% of GP using it pre-COVID to 5% during the pandemic.

Register-and-join-Health-Industry-Hub-Pharma-MedTech-Biotech

But, when combined with the increase in Live Chat, 13% of GPs responded with these virtual solutions as their preferred way of being contacted in the future (up from 3% pre-COVID). At the same time, in-person field staff visits have dropped from 81% to 50% preferring this contact form post-COVID.

Recently, Medicines Australia’s released guidance around field staff returning to practices, urging the need to be agile and flexible when working with their healthcare professional colleagues. When asked if they agreed with this approach, 43% of GPs said they did, with only 4% saying they did not.

Medicines Australia CEO Elizabeth de Somer congratulated field staff on their responsiveness to the crisis “At the outset of industry’s response to the COVID-19 crisis, members reacted quickly to protect the safety of our sales forces and those they interact with by reducing face-to-face interactions with healthcare professionals.

“The educational interaction between a healthcare professional and a pharmaceutical field rep is an important reciprocal relationship and we are pleased that this will continue under our new normal,” said Ms de Somer.

“Healthcare professionals and clinicians have adopted virtual meetings widely, and this positive survey result is validation that this is appreciated,” said Ms de Somer.


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

Medical

Medical Pharma Biotech MedTech - Medical researchers support interim budget measures and urge longer-term sustainability - Research Australia

Medical researchers support interim budget measures and urge longer-term sustainability

Health Industry Hub | September 28, 2020 |

Medical News: The $700 million bail-out package for university researchers flagged for consideration in the upcoming federal budget would be […]

More


Digital & Innovation

Healthcare Technology Digital Innovations - Pfizer Australia backs digital health start-ups, an interview with Country Medical Director Dr Krishan Thiru

Pfizer Australia backs digital health start-ups, an interview with Country Medical Director

Health Industry Hub | September 28, 2020 |

Digital & Innovation: The recent Innovate Health virtual event aimed at navigating commercialisation, accelerating growth and uptake of digital health […]

More


News & Trends - Medical Technology

MedTech News - Documentation of COVID-19 screening fell short of national imperative in Australian hospitals

Documentation of COVID-19 screening fell short of national imperative in Australian hospitals, says new study

Health Industry Hub | September 28, 2020 |

MedTech News: New Australian research on COVID-19 screening of hospital patients during the first wave of the pandemic found that […]

More


News & Trends - Pharmaceuticals

Pharma News - Roche's haemophilia treatment available at no cost to patients

Roche’s haemophilia treatment available at no cost to patients

Health Industry Hub | September 28, 2020 |

Pharma News: The Australian government have agreed to fund a new treatment for haemophilia patients, through the national blood arrangements. […]

More